Lori Kunkel, M.D.

Lori Kunkel, M.D.

DirectoratOric Pharmaceuticals· In proxies 2023–2025

Lori Kunkel, M.D. sits on 7 public boards.

Experience

  1. Oric PharmaceuticalsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +71%
  2. Enliven Therapeutics, Inc.Public company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  3. K36 Therapeutics, Inc.Public company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  4. Nurix Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. Curis, Inc.Public company · 6 yr
    • Director2016 – 2022 · 6 yrNo stock prices for these years
  6. Maverick Therapeutics, Inc.Public company · 4 yr
    • Director2017 – 2021 · 4 yrNo stock prices for these years
  7. Tocagen Inc.Public company · 5 yr
    • Director2015 – 2020 · 5 yrNo stock prices for these years
  8. Loxo Oncology, Inc.Public company · 5 yr
    • Director2014 – 2019 · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?